Synthesis and anti-tumor activities of novel pyrazolo[1,5-a]pyrimidines. 2006

Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, P. R. China.

A series of novel pyrazolo[1,5-a]pyrimidines were designed and synthesized in order to find novel potent anti-tumor compounds. The structures of all the compounds were confirmed by IR, (1)H-NMR, elemental analysis, and MS. Their anti-tumor activities against cancer cell lines were tested by the MTT method in vitro. Compound 19 displayed potent anti-tumor activity.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
September 2009, European journal of medicinal chemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
May 2007, Molecules (Basel, Switzerland),
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
January 2023, Bioorganic & medicinal chemistry letters,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
January 2020, Bioorganic chemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
March 1975, Journal of medicinal chemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
May 1981, Journal of medicinal chemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
August 2011, Molecules (Basel, Switzerland),
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
September 2013, Ultrasonics sonochemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
December 2021, Bioorganic chemistry,
Juan Li, and Yan Fang Zhao, and Xiang Lin Zhao, and Xiao Ye Yuan, and Ping Gong
October 1995, Die Pharmazie,
Copied contents to your clipboard!